Summary of Systemic Lupus Erythematosus and Its Impact Systemic lupus erythematosus (SLE) is a complex autoimmune disease that causes widespread inflammation and organ damage, primarily affecting the skin, kidneys, and cardiovascular system. The …
Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE), affecting about 60% of patients and leading to kidney inflammation and dysfunction. Current treatments, primarily corticosteroids combined with immunosuppressive …
Lupus nephritis (LN) is a serious complication affecting 50-60% of systemic lupus erythematosus (SLE) patients, leading to kidney inflammation and potential end-stage renal disease (ESRD). Recent research highlights the role of remnant cholesterol …
Neonatal lupus erythematosus (NLE) is a rare autoimmune condition affecting newborns due to maternal autoantibodies, primarily anti-SSA/Ro and anti-SSB/La. It can lead to serious complications such as congenital heart block (CHB), skin rashes, and …
Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder marked by antiphospholipid antibodies (aPLs), leading to recurrent thrombosis and obstetric complications. It can be primary or secondary, commonly associated with systemic lupus …
Lupus, particularly systemic lupus erythematosus (SLE), is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues, leading to inflammation and potential damage to various organs such as the skin, joints, kidneys, and …
The article discusses the management of lupus through medication, lifestyle modifications, and self-care practices. Key medications include NSAIDs for pain relief, corticosteroids for severe symptoms, antimalarial drugs like hydroxychloroquine for …
Pericarditis is an inflammatory condition affecting the pericardium, particularly common in lupus patients. Key symptoms include sharp chest pain that worsens with breathing, fever, fatigue, palpitations, and shortness of breath. Diagnosis involves …
The article provides a comprehensive overview of systemic lupus erythematosus (SLE) from a childhood perspective, highlighting its characteristics as a chronic autoimmune disease where the immune system produces autoantibodies that attack healthy …
Lupkynis (voclosporin) is an FDA-approved treatment for lupus nephritis, a serious complication of systemic lupus erythematosus (SLE). While it effectively manages kidney inflammation when combined with other immunosuppressive agents, it can cause …
The article discusses the significant health disparities affecting lupus diagnosis and treatment, particularly among African Americans. It highlights barriers such as limited healthcare access, socioeconomic challenges, and a lack of awareness about …
